Yondelis (trabectedin, ET-743): the development of an anticancer agent of marine origin.

van Kesteren, Ch

Yondelis (trabectedin, ET-743): the development of an anticancer agent of marine origin. [electronic resource] - Anti-cancer drugs Aug 2003 - 487-502 p. digital

Publication Type: Journal Article; Review

0959-4973

10.1097/00001813-200308000-00001 doi


Animals
Antineoplastic Agents, Alkylating--adverse effects
Cell Cycle--drug effects
Chemistry, Pharmaceutical
Clinical Trials as Topic
Dioxoles--adverse effects
Female
Humans
Isoquinolines--adverse effects
Neoplasms--drug therapy
Tetrahydroisoquinolines
Trabectedin